Guidelines for treatment of drug-susceptible tuberculosisand patient care
2017 Update
Expert opinion of the European Tuberculosis Laboratory Initiative core group members for the WHO European Region.
A survival guide for clinicans.
3rd edition.
The use of Delamanid and Bedaquiline for Children with Drug-Resistant Tuberculosis.
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
Retention of knowledge and application within the community one year later